Advertisement
Annals
Established in 1927 by the American College of Physicians
:
Advanced search

box In this Issue
  arrow Articles
  arrow Brief Communications
  arrow Academia and Clinic
  arrow Reviews
  arrow Perspectives
  arrow Medicine and Public Issues
  arrow Editorials
  arrow On Being a Doctor
  arrow Letters
  arrow Medical Writings: Book Notes
  arrow Currents
  arrow Ad Libitum
  arrow Ancillary Content
  arrow Summaries for Patients
  arrow PDF of Contents
box Services
  arrow Subscribe
  arrow One-time access
  arrow Activate online subscription
  arrow Access Personal Archive
 
box In this Issue
  arrow Articles
  arrow Brief Communications
  arrow Academia and Clinic
  arrow Reviews
  arrow Perspectives
  arrow Medicine and Public Issues
  arrow Editorials
  arrow On Being a Doctor
  arrow Letters
  arrow Medical Writings: Book Notes
  arrow Currents
  arrow Ad Libitum
  arrow Ancillary Content
  arrow Summaries for Patients
  arrow PDF of Contents
box Services
  arrow Subscribe
  arrow One-time access
  arrow Activate online subscription
  arrow Access Personal Archive
 

TABLE OF CONTENTS

16 May 2000 Volume 132 Issue 10
< Previous Issue  |  Next Issue >
Clear

Articles Back

Lisa A. Prosser, Aaron A. Stinnett, Paula A. Goldman, Lawrence W. Williams, Maria G.M. Hunink, Lee Goldman, and Milton C. Weinstein

Cost-effectiveness of cholesterol-lowering treatments was found to vary significantly when adjusted for sex, age, and the presence or absence of additional risk factors. Primary prevention with a step I diet seems to be cost-effective for most risk subgroups but not for otherwise healthy young women. Primary prevention with a statin may not be cost-effective for younger men and women with few risk factors, given the option of secondary prevention and of primary prevention in older age ranges.

Abstract | Full Text | PDF | Summary for Patients

David A. Ganz, Karen M. Kuntz, Gretchen A. Jacobson, and Jerry Avorn

The cost-effectiveness ratios of statin therapy in older patients who have previously had myocardial infarction are reasonable under a variety of assumptions about drug efficacy, drug cost, and rates of cardiac and cerebrovascular events. Pending results of randomized, controlled trials of secondary prevention in patients in this age group, statin therapy seems to be as cost-effective as many routinely accepted medical interventions in this setting.

Abstract | Full Text | PDF | Summary for Patients

Kishan J. Pandya, Richard F. Raubertas, Patrick J. Flynn, Harry E. Hynes, Richard J. Rosenbluth, Jeffrey J. Kirshner, H. Irving Pierce, Vladimir Dragalin, and Gary R. Morrow

Oral clonidine at a dosage of 1 mg/d is effective against tamoxifen-induced hot flashes in postmenopausal women with breast cancer.

Abstract | Full Text | PDF | Summary for Patients


Brief Communications Back

Han-Mou Tsai, Lawrence Rice, Ravindra Sarode, Thomas W. Chow, and Joel L. Moake

In patients who developed ticlopidine-associated thrombotic thrombocytopenic purpura (TTP), autoantibodies to von Willebrand factor metalloproteinase were formed; this led to the same type of von Willebrand factor abnormalities seen in patients with idiopathic acute TTP. The findings suggest that failure to process large and unusually large von Willebrand factor multimers in vivo caused binding of von Willebrand factor to platelets, systemic platelet thrombosis, and TTP.

Abstract | Full Text | PDF | Summary for Patients

Konstantinos Raymondos, Bernhard Panning, Martin Leuwer, Guido Brechelt, Thomas Korte, Michael Niehaus, Jürgen Tebbenjohanns, and Siegfried Piepenbrock

This prospective study demonstrates that administration of adrenaline into the airways is hemodynamically effective and increases adrenaline plasma levels in adults with severe cardiac disease.

Abstract | Full Text | PDF | Summary for Patients


Academia and Clinic Back

James E. Smith, Robert L. Winkler, and Dennis G. Fryback

Computing the positive predictive value (PPV) is difficult in the case of a new test for a rare disorder. The authors present some tools for thinking about PPV calculations for such scenarios.

Abstract | Full Text | PDF


Reviews Back

Kavita Nanda, Douglas C. McCrory, Evan R. Myers, Lori A. Bastian, Vic Hasselblad, Jason D. Hickey, and David B. Matchar

Available high-quality data are insufficient to allow estimation of test operating characteristics of new cytologic methods for cervical screening. Future studies of these technologies should apply adequate reference standards. Most studies of the conventional Papanicolaou test are severely biased: The best estimates suggest that the test is only moderately accurate and does not achieve concurrently high sensitivity and specificity.

Abstract | Full Text | PDF


Perspectives Back

Karen E. Steinhauser, Elizabeth C. Clipp, Maya McNeilly, Nicholas A. Christakis, Lauren M. McIntyre, and James A. Tulsky

This study describes the attributes of a good death, as understood by various participants in end-of-life care.

Abstract | Full Text | PDF


Medicine and Public Issues Back

Robert Dickler and Gina Shaw

The authors examine the overall financial and organizational effect of the Balanced Budget Act of 1997 on teaching hospitals in the United States and consider its effect on residency education.

Abstract | Full Text | PDF


Editorials Back

Alan M. Garber

The studies by Ganz and Prosser and their colleagues in this issue evaluate statin therapy in clinically important populations that were not studied adequately in randomized trials. These studies reinforce the message that lipid management for secondary prevention should be a high priority, regardless of whether the patient is female or male, young or old.

Full Text | PDF


On Being a Doctor Back

Bruce Leff

How had such a ripe opportunity for a "good" death been botched so badly, and why had so many people experienced such suffering?

Full Text | PDF

Bhuvana Chandra

Full Text | PDF


Letters Back

Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation

    Robert G. Hart and Lesly A. Pearce—RESPONSE

    Full Text | PDF

Chronic Infection and Coronary Risk

Elevated Ambulatory and Normal Office Blood Pressure

    Thomas G. Pickering, Jennifer E. Liu, and Mary J. Roman—RESPONSE

    Full Text | PDF

The Sharer

Diagnosis of Intercritical Gout

    Eliseo Pascual, Enrique Batlle-Gualda, and Agustín Martínez—RESPONSE

    Full Text | PDF

Transmission of Tuberculosis in a Jail

Prophylactic Fluconazole in Liver Transplant Recipients

Role of Communication Skills Training

Update in Preventive Medicine

Gated Myocardial Perfusion Scan Leading to Diagnosis of Unsuspected Massive Pulmonary Embolism

Infection with Hepatitis C Virus Genotype 4 Is Associated with a Poor Response to Interferon-{alpha}

    Hervé Zylberberg, M. L. Chaix, and Christian Bréchot

    Full Text | PDF

A Common Problem with Therapy for HIV Infection

    Marcial Delgado Fernández, José Luis Zambrana García, and Felipe Díez García

    Full Text | PDF

Most Gastric Low-Grade B-Cell Lymphomas of Mucosa-Associated Lymphoid Tissue Persist after Helicobacter pylori Eradication

    Graziella Pinotti, Claudio Chini, and Carlo Capella

    Full Text | PDF

Immediate Cerebral Angiography and Mechanical Fragmentation of Cerebral Embolus after Percutaneous Myocardial Revascularization

    Eelco F.M. Wijdicks, Kent R. Thielen, and Guy S. Reeder

    Full Text | PDF

Rapid Bioprosthetic Valve Degeneration in a Patient Undergoing Hemodialysis



Medical Writings: Book Notes Back

Gerald Schulman

Full Text | PDF

Christopher Maylahn

Full Text | PDF


Currents Back

Linda Gundersen

Full Text


Ad Libitum Back

George N. Braman

Full Text | PDF

Carolyn Theresa Cleary

Full Text | PDF


Ancillary Content Back

Full Text

Full Text | PDF


Summaries for Patients Back

Full Text | PDF

Full Text | PDF

Full Text | PDF

Full Text | PDF

Full Text | PDF



 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2008 by the American College of Physicians.